rs333

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_001394783.1(CCR5):​c.554_585delGTCAGTATCAATTCTGGAAGAATTTCCAGACA​(p.Ser185IlefsTer32) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0977 in 1,613,870 control chromosomes in the GnomAD database, including 8,868 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.072 ( 553 hom., cov: 31)
Exomes 𝑓: 0.10 ( 8315 hom. )

Consequence

CCR5
NM_001394783.1 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:4O:2

Conservation

PhyloP100: 0.894

Publications

205 publications found
Variant links:
Genes affected
CCR5 (HGNC:1606): (C-C motif chemokine receptor 5) This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2015]
CCR5AS (HGNC:54398): (CCR5 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 3-46373452-TACAGTCAGTATCAATTCTGGAAGAATTTCCAG-T is Benign according to our data. Variant chr3-46373452-TACAGTCAGTATCAATTCTGGAAGAATTTCCAG-T is described in ClinVar as Benign. ClinVar VariationId is 8184.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCR5NM_001394783.1 linkc.554_585delGTCAGTATCAATTCTGGAAGAATTTCCAGACA p.Ser185IlefsTer32 frameshift_variant Exon 2 of 2 ENST00000292303.5 NP_001381712.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCR5ENST00000292303.5 linkc.554_585delGTCAGTATCAATTCTGGAAGAATTTCCAGACA p.Ser185IlefsTer32 frameshift_variant Exon 2 of 2 1 NM_001394783.1 ENSP00000292303.4 P51681

Frequencies

GnomAD3 genomes
AF:
0.0718
AC:
10911
AN:
152034
Hom.:
553
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0204
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.0370
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0135
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.0483
GnomAD2 exomes
AF:
0.0743
AC:
18640
AN:
251006
AF XY:
0.0745
show subpopulations
Gnomad AFR exome
AF:
0.0192
Gnomad AMR exome
AF:
0.0293
Gnomad ASJ exome
AF:
0.129
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.134
Gnomad NFE exome
AF:
0.108
Gnomad OTH exome
AF:
0.0726
GnomAD4 exome
AF:
0.100
AC:
146811
AN:
1461718
Hom.:
8315
AF XY:
0.0983
AC XY:
71450
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.0154
AC:
514
AN:
33478
American (AMR)
AF:
0.0303
AC:
1356
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
3418
AN:
26132
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0171
AC:
1477
AN:
86258
European-Finnish (FIN)
AF:
0.131
AC:
6981
AN:
53368
Middle Eastern (MID)
AF:
0.0151
AC:
87
AN:
5768
European-Non Finnish (NFE)
AF:
0.115
AC:
127679
AN:
1111894
Other (OTH)
AF:
0.0877
AC:
5295
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
7780
15559
23339
31118
38898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4540
9080
13620
18160
22700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0717
AC:
10914
AN:
152152
Hom.:
553
Cov.:
31
AF XY:
0.0707
AC XY:
5259
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0203
AC:
844
AN:
41550
American (AMR)
AF:
0.0370
AC:
565
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
452
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0141
AC:
68
AN:
4820
European-Finnish (FIN)
AF:
0.135
AC:
1428
AN:
10580
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.107
AC:
7285
AN:
67954
Other (OTH)
AF:
0.0478
AC:
101
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
511
1022
1534
2045
2556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0929
Hom.:
121
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0915
EpiControl
AF:
0.0970

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

CCR5-related disorder Benign:1
May 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Susceptibility to HIV infection Benign:1
Dec 01, 2008
OMIM
Significance:protective
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Benign:1
Nov 22, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Resistance to hepatitis C virus Benign:1
Dec 01, 2008
OMIM
Significance:protective
Review Status:no assertion criteria provided
Collection Method:literature only

- -

West Nile virus, susceptibility to Other:1
Dec 01, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Multiple sclerosis modifier of disease progression Other:1
Dec 01, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.89
Mutation Taster
=185/15
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs333; hg19: chr3-46414943; COSMIC: COSV52750809; API